These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 12384784)

  • 21. High variability in CYP21A2 mutated alleles in Spanish 21-hydroxylase deficiency patients, six novel mutations and a founder effect.
    Loidi L; Quinteiro C; Parajes S; Barreiro J; Lestón DG; Cabezas-Agrícola JM; Sueiro AM; Araujo-Vilar D; Catro-Feijóo L; Costas J; Pombo M; Domínguez F
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):330-6. PubMed ID: 16487445
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutation-haplotype analysis of steroid 21-hydroxylase (CYP21) deficiency in Finland. Implications for the population history of defective alleles.
    Levo A; Partanen J
    Hum Genet; 1997 Apr; 99(4):488-97. PubMed ID: 9099839
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Linkage analysis of the C4A/C4B copy number variation and polymorphisms of the adjacent steroid 21-hydroxylase gene in a healthy population.
    Blaskó B; Bánlaki Z; Gyapay G; Pozsonyi E; Sasvári-Székely M; Rajczy K; Füst G; Szilágyi A
    Mol Immunol; 2009 Aug; 46(13):2623-9. PubMed ID: 19505723
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carriership of a defective tenascin-X gene in steroid 21-hydroxylase deficiency patients: TNXB -TNXA hybrids in apparent large-scale gene conversions.
    Koppens PF; Hoogenboezem T; Degenhart HJ
    Hum Mol Genet; 2002 Oct; 11(21):2581-90. PubMed ID: 12354783
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predisposition for de novo gene aberrations in the offspring of mothers with a duplicated CYP21A2 gene.
    Baumgartner-Parzer SM; Fischer G; Vierhapper H
    J Clin Endocrinol Metab; 2007 Mar; 92(3):1164-7. PubMed ID: 17164306
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comprehensive mutation analysis of the CYP21A2 gene: an efficient multistep approach to the molecular diagnosis of congenital adrenal hyperplasia.
    Xu Z; Chen W; Merke DP; McDonnell NB
    J Mol Diagn; 2013 Nov; 15(6):745-53. PubMed ID: 24071710
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diversity of the CYP21A2 gene: a 6.2-kb TaqI fragment and a 3.2-kb TaqI fragment mistaken as CYP21A1P.
    Lee HH; Tsai FJ; Lee YJ; Yang YC
    Mol Genet Metab; 2006 Aug; 88(4):372-7. PubMed ID: 16684614
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A new CYP21A1P/CYP21A2 chimeric gene identified in an Italian woman suffering from classical congenital adrenal hyperplasia form.
    Concolino P; Mello E; Minucci A; Giardina E; Zuppi C; Toscano V; Capoluongo E
    BMC Med Genet; 2009 Jul; 10():72. PubMed ID: 19624807
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carrier frequency of congenital adrenal hyperplasia (21-hydroxylase deficiency) in a middle European population.
    Baumgartner-Parzer SM; Nowotny P; Heinze G; Waldhäusl W; Vierhapper H
    J Clin Endocrinol Metab; 2005 Feb; 90(2):775-8. PubMed ID: 15572419
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of TaqI digestion may lead to incorrect molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Lee HH; de Wijs IJ; Sistermans EA
    Mol Genet Metab; 2000 Aug; 70(4):322-4. PubMed ID: 10993720
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Haplotypes of the steroid 21-hydroxylase gene region encoding mild steroid 21-hydroxylase deficiency.
    Haglund-Stengler B; Martin Ritzén E; Gustafsson J; Luthman H
    Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8352-6. PubMed ID: 1924294
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Who is a carrier? Detection of unsuspected mutations in 21-hydroxylase deficiency.
    Witchel SS; Lee PA; Trucco M
    Am J Med Genet; 1996 Jan; 61(1):2-9. PubMed ID: 8741909
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Application of the DHPLC method for mutational detection of the CYP21A2 gene in congenital adrenal hyperplasia.
    Tsai LP; Cheng CF; Hsieh JP; Teng MS; Lee HH
    Clin Chim Acta; 2009 Dec; 410(1-2):48-53. PubMed ID: 19778530
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular analysis of patient and carrier genes with congenital steroid 21-hydroxylase deficiency by using polymerase chain reaction and single strand conformation polymorphism.
    Tajima T; Fujieda K; Nakayama K; Fujii-Kuriyama Y
    J Clin Invest; 1993 Nov; 92(5):2182-90. PubMed ID: 8227333
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A rare CYP21A2 haplotype clarifies the phenotype-genotype discrepancy in an Italian patient with Non Classical Congenital Adrenal Hyperplasia (NC-CAH).
    Concolino P
    Mol Biol Rep; 2020 Apr; 47(4):3049-3052. PubMed ID: 32185686
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A unique haplotype of RCCX copy number variation: from the clinics of congenital adrenal hyperplasia to evolutionary genetics.
    Doleschall M; Luczay A; Koncz K; Hadzsiev K; Erhardt É; Szilágyi Á; Doleschall Z; Németh K; Török D; Prohászka Z; Gereben B; Fekete G; Gláz E; Igaz P; Korbonits M; Tóth M; Rácz K; Patócs A
    Eur J Hum Genet; 2017 Jun; 25(6):702-710. PubMed ID: 28401898
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 21-Hydroxylase and 11beta-hydroxylase mutations in Romanian patients with classic congenital adrenal hyperplasia.
    Grigorescu Sido A; Weber MM; Grigorescu Sido P; Clausmeyer S; Heinrich U; Schulze E
    J Clin Endocrinol Metab; 2005 Oct; 90(10):5769-73. PubMed ID: 16046588
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Variants of the CYP21A2 and CYP21A1P genes in congenital adrenal hyperplasia.
    Lee HH
    Clin Chim Acta; 2013 Mar; 418():37-44. PubMed ID: 23313747
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High frequency of copy number variations and sequence variants at CYP21A2 locus: implication for the genetic diagnosis of 21-hydroxylase deficiency.
    Parajes S; Quinteiro C; Domínguez F; Loidi L
    PLoS One; 2008 May; 3(5):e2138. PubMed ID: 18478071
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The pathogenic p.Gln319Ter variant is not causing congenital adrenal hyperplasia when inherited in one of the duplicated CYP21A2 genes.
    Fanis P; Skordis N; Toumba M; Picolos M; Tanteles GA; Neocleous V; Phylactou LA
    Front Endocrinol (Lausanne); 2023; 14():1156616. PubMed ID: 37324257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.